Follow
Gregory Gan
Gregory Gan
University of Kansas Medical Center
Verified email at kumc.edu
Title
Cited by
Cited by
Year
Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non–small-cell lung cancer
AJ Weickhardt, B Scheier, JM Burke, G Gan, X Lu, PA Bunn Jr, DL Aisner, ...
Journal of Thoracic Oncology 7 (12), 1807-1814, 2012
6842012
Unexplored therapeutic opportunities in the human genome
TI Oprea, CG Bologa, S Brunak, A Campbell, GN Gan, A Gaulton, ...
Nature reviews Drug discovery 17 (5), 317-332, 2018
3552018
DNA polymerase zeta (pol ζ) in higher eukaryotes
GN Gan, JP Wittschieben, BØ Wittschieben, RD Wood
Cell research 18 (1), 174-183, 2008
2582008
Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer
S Beriwal, GN Gan, DE Heron, RN Selvaraj, H Kim, R Lalonde, JL Kelley, ...
International Journal of Radiation Oncology* Biology* Physics 68 (1), 166-171, 2007
1962007
Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer …
GN Gan, AJ Weickhardt, B Scheier, RC Doebele, LE Gaspar, ...
International Journal of Radiation Oncology* Biology* Physics 88 (4), 892-898, 2014
1952014
Effects of conditional overexpression of spermidine/spermine N 1-acetyltransferase on polyamine pool dynamics, cell growth, and sensitivity to polyamine analogs
S Vujcic, M Halmekytö, P Diegelman, G Gan, DL Kramer, J Jänne, ...
Journal of Biological Chemistry 275 (49), 38319-38328, 2000
1412000
XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer
JJ Morton, G Bird, SB Keysar, DP Astling, TR Lyons, RT Anderson, ...
Oncogene 35 (3), 290-300, 2016
1332016
Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancer
SB Keysar, PN Le, RT Anderson, JJ Morton, DW Bowles, JJ Paylor, ...
Cancer research 73 (11), 3381-3392, 2013
1042013
Pediatric CNS tumors
N Gupta, A Banerjee, D Haas-Kogan
Springer Science & Business Media, 2010
752010
Hedgehog signaling drives radioresistance and stroma-driven tumor repopulation in head and neck squamous cancers
GN Gan, J Eagles, SB Keysar, G Wang, MJ Glogowska, C Altunbas, ...
Cancer research 74 (23), 7024-7036, 2014
712014
Inhibition of MK2 suppresses IL‐1β, IL‐6, and TNF‐α‐dependent colorectal cancer growth
AL Ray, KL Berggren, S Restrepo Cruz, GN Gan, EJ Beswick
International journal of cancer 142 (8), 1702-1711, 2018
672018
Evaluation of safety of stereotactic body radiotherapy for the treatment of patients with multiple metastases: findings from the NRG-BR001 phase 1 trial
S Chmura, KA Winter, C Robinson, TM Pisansky, V Borges, H Al-Hallaq, ...
JAMA oncology 7 (6), 845-852, 2021
622021
A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with Advanced …
LL Siu, EK Rowinsky, LA Hammond, GR Weiss, M Hidalgo, GM Clark, ...
Clinical cancer research 8 (7), 2157-2166, 2002
542002
Daily diary study of hope, stigma, and functioning in lung cancer patients.
LE Steffen, KE Vowles, BW Smith, GN Gan, MJ Edelman
Health Psychology 37 (3), 218, 2018
372018
Recent advances in targetable therapeutics in metastatic non-squamous NSCLC
P Bansal, D Osman, GN Gan, GR Simon, Y Boumber
Frontiers in oncology 6, 195170, 2016
352016
The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomas
RT Anderson, SB Keysar, DW Bowles, MJ Glogowska, DP Astling, ...
Molecular cancer therapeutics 12 (10), 1994-2005, 2013
352013
Recent advances in immunotherapy in metastatic NSCLC
P Bansal, D Osman, GN Gan, GR Simon, Y Boumber
Frontiers in oncology 6, 220253, 2016
322016
Emerging from their burrow: Hedgehog pathway inhibitors for cancer
GN Gan, A Jimeno
Expert opinion on investigational drugs 25 (10), 1153-1166, 2016
312016
Phase I trial of stereotactic body radiation therapy (SBRT) to multiple metastatic sites: a NRG oncology study
SJ Chmura, K Winter, JK Salama, CG Robinson, TM Pisansky, V Borges, ...
International Journal of Radiation Oncology, Biology, Physics 102 (3), S68-S69, 2018
302018
Stereotactic body radiotherapy as primary therapy for head and neck cancer in the elderly or patients with poor performance
A Amini, JD McDermott, G Gan, S Bhatia, W Sumner, CM Fisher, A Jimeno, ...
Frontiers in Oncology 4, 274, 2014
292014
The system can't perform the operation now. Try again later.
Articles 1–20